J. Wagner

发表

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease.

S. Davies, D. Weisdorf, B. Blazar, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution.

E. Farmer, R. Corio, G. Vogelsang, 1994, Archives of dermatology.

Graft versus host disease

G. Vogelsang, J. Wagner, J. E. Wagner, 1990, Bone Marrow Transplantation.

The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation

J Wagner, K. Sullivan, R. Storb, 1998, Bone Marrow Transplantation.

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

M. Tallman, O. Ringdén, R. Martino, 2004, Bone Marrow Transplantation.

Pathogenesis and pathology of graft-vs.-host disease.

G. Vogelsang, W. Beschorner, J. Wagner, 1989, American Journal Of Pediatric Hematology/Oncology.

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

C. Ebens, S. Terezakis, V. Bachanova, 2022, medRxiv.

Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors.

J. Wagner, D. Weisdorf, D J Weisdorf, 2001, The New England journal of medicine.

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

J. Klein, J. Wagner, M. Horowitz, 2000, The New England journal of medicine.

Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation.

J. Wagner, M. Cairo, J. Wagner, 1997, Blood.

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation.

R. Collins, J. Wagner, R. Koup, 2001, Blood.

TALEN-based gene correction for epidermolysis bullosa.

Christof von Kalle, Jakub Tolar, Richard Gabriel, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Generation and Large‐Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft‐Versus‐Host Disease

J. Wagner, C. June, B. Blazar, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

P. Kaplan, V. Cool, S. Packman, 1996, Blood.

Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial

J. Wagner, M. MacMillan, B. Blazar, 2009, Bone Marrow Transplantation.

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

J. Wagner, J. Kurtzberg, S. Gerson, 2001, The New England journal of medicine.

Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures.

J. Wagner, J. Kurtzberg, M. Cairo, 1998, Journal of hematotherapy.

Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.

J. Wagner, S. Davies, M. Cairo, 1996, Blood.

Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.

J. Wagner, C. Verfaillie, Jeffrey S. Miller, 2001, The American journal of medicine.

Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 1995, Blood.

Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation.

J. Wagner, E. Pamer, B. Blazar, 2000, Blood.

Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival

J. Wagner, D. Weisdorf, M. Verneris, 2009, Bone Marrow Transplantation.

Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial.

J. Wagner, B. Zehnbauer, A. Donnenberg, 1990, Blood.

Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.

J. Wagner, J. Kurtzberg, M. Trigg, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

J. Wagner, S. Davies, D. Weisdorf, 2001, Blood.

Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients

J. Wagner, D. Weisdorf, M. Verneris, 2009, Bone Marrow Transplantation.

Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application.

J. Wagner, C. Almici, C. Carlo-Stella, 1995, Haematologica.

Effective treatment of α-mannosidosis by allogeneic hematopoietic stem cell transplantation

J. Wagner, S. Davies, P. Orchard, 2004 .

Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.

David A. Williams, C. von Kalle, J. Wagner, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.